It has been known for many years that an increased CD4+ T-cell stimulation in SLE patients leads to the accumulation of terminal differentiated effector memory T cells with decreased proliferative capacity and increased apoptosis sensitivity [22–25]. The gene discussed is CD4; the disease is systemic lupus erythematosus.